Neuronetwork For Emerging Therapies

Where scientists create cures.
Drs. Laura DeVault, Eva Feldman and Bhumsoo Kim in lab coats in the lab looking at a monitor

Our goal is to accelerate scientific discovery to alleviate suffering in neurological diseases. 

Our work in recent years highlights that we will not reach this goal alone. Every day, we work with a passionate, innovative, multidisciplinary team of researchers and physician-scientists at the forefront of biomedical research. 

We draw upon our expertise and our innovative collaborations, both within the University of Michigan and worldwide, to accelerate the pace of scientific discovery and support emerging therapies for neurological diseases. 

Explore the Neuronetwork For Emerging Therapies

About

Learn about the NeuroNetwork for Emerging Therapies at Michigan Medicine.

People

Meet the diverse team behind the NeuroNetwork for Emerging Therapies.

Research

Learn about the scientific discovery at the NeuroNetwork for Emerging Therapies.

Giving

Support our scientists in creating cures.

Interdisciplinary collaboration allows us to leverage advanced technologies with our colleagues in genetics, physiology, environmental science, and bioinformatics. This synergy drives breakthroughs in our understanding of brain health and brain diseases. Our partnerships will lead to more personalized and effective treatment options for our patients.

Eva L. Feldman, M.D., Ph.D.
James W. Albers Distinguished University Professor and Russell N. DeJong Professor of Neurology
photo of Dr. Eva Feldman
blue state of michigan on a maize background
Announcing

It’s Now Mandatory to Report ALS in Michigan

Michigan has become the fifth state to establish a mandatory reporting rule for ALS cases due to the efforts of the ALS Center of Excellence, which could prove to be a catalyst for ALS research and prevention.

Learn more

Sign up for our newsletter

Sign up

View past issues of our newsletter

Click here
Drs. Cali McEntee and Eva Feldman looking at test tubes in the lab
Join us

Support Scientists Creating Cures

Your help will advance cutting-edge research in brain health, ALS, and the neurologic complications of diabetes and obesity, with the goal of translating knowledge gained in the laboratory into new therapies.

Support our research

Internship Opportunities

Click Here

news

See All News
Research News

Understanding Gene Activity to Advance ALS Diagnosis and Treatment

A new grant from the National Institute of Neurological Disorders and Stroke aims to improve the diagnosis of ALS, better predict disease progression, and identify new treatment options.
a tractor spraying pesticides on a planted field
Research News

NBC News Features Dr. Stephen Goutman

NBC News interviewed Dr. Stephen Goutman about the link between pesticides and ALS.
photo of Dr. Eva Feldman
Research News

Dr. Feldman joins the Biointerfaces Institute

Dr. Feldman joins the Biointerfaces Institute
Research News

Linking peripheral neuropathy and dementia

A new review discusses the mechanisms connecting the two conditions and coins a new term to describe it – "stocking-glove-hat.”
A women standing in front of the mirror with Post-its
Research News

Morning tips to keep your brain sharp

Reader's Digest's The Healthy interviewed Dr. Eva L. Feldman about what to do in the morning to keep your brain sharp.
A screenshot of the homepage of The Washington Post website
Research News

ALS in The Washington Post

Dr. Eva Feldman was interviewed by The Washington Post about the current state of ALS research.

EVENTS

9 25 2026 2:30 pm 9 25 2026

Scott Pranger ALS Center Symposium

The first of an annual symposium that will celebrate the naming of the Scott Pranger ALS Center at Michigan Medicine on September 25, 2026, at 2:30 p.m., in the Kahn Auditorium of the A. Alfred Taubman Biomedical Science Research Building. The event features a recorded discussion with award-winning CNN chief medical correspondent Sanjay Gupta, MD.
Sanjay Gupta, MD